Hi there!
We track 70,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
Visterra
Visterra is a clinical stage biotechnology company committed to developing innovative antibody-based therapies for the treatment of patients with kidney diseases and other hard-to-treat diseases. Our…
Visterra
Visterra is a clinical stage biotechnology company committed to developing innovative antibody-based therapies for the treatment of patients with kidney diseases and other hard-to-treat diseases. Our…
TL;DR
Stage: Acquired (July 2018)
Founded: 2007
Headquarters: Cambridge, Massachusetts
Focus: Antibody-based therapeutics for immune-mediated and hard-to-treat diseases
Company Overview
Problem Domain
Therapeutics for immune-mediated, infectious, and kidney diseases with unmet medical needs.
Founded
2007
Industry
Research Services
Funding Track Record
$430M
Acquired by Otsuka Pharmaceutical in July 2018 for $430M
Investor Signal
“Flagship Pioneering; Bill & Melinda Gates Foundation listed among investors”
Founders
What we do
Join the Team
Startup jobs. A lot of them.
Your next opportunity is in here somewhere. Sign up to explore 70,000+ startups and their open roles. No spam. No gamification. Just jobs.
70,000+
Startups
82,000+
Open Roles
3,800+
New This Week